Seung T. Lim

St. Vincent's Hospital
Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Microbiological and clinical outcomes of single-stage minimal excision of inflamed epidermal cysts without routine antibiotic treatments: A dual-center retrospective cohort study.

Microbiological and clinical outcomes of single-stage minimal excision of inflamed epidermal cysts without routine antibiotic treatments: A dual-center retrospective cohort study.

Journal: Medicine

Published: November 03, 2025

Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy.

Clinical Impact of TP53 Mutations in Patients with Head and Neck Cancer Who Were Treated with Targeted Therapies or Immunotherapy.

Journal: Cancer research and treatment

Published: August 28, 2024

Prognostic Implications of Maintaining the Target Thyroid-Stimulating Hormone Status Based on the 2015 American Thyroid Association Guidelines in Patients with Low-Risk Papillary Thyroid Carcinoma after Lobectomy: A 5-Year Landmark Analysis.

Prognostic Implications of Maintaining the Target Thyroid-Stimulating Hormone Status Based on the 2015 American Thyroid Association Guidelines in Patients with Low-Risk Papillary Thyroid Carcinoma after Lobectomy: A 5-Year Landmark Analysis.

Journal: Cancers

Published: August 08, 2024

Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer.

Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer.

Journal: Scientific reports

Published: July 08, 2024

Machine learning models for prediction of lymph node metastasis in patients with T1b gastric cancer.

Machine learning models for prediction of lymph node metastasis in patients with T1b gastric cancer.

Journal: American journal of cancer research

Published: June 19, 2024

Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.

Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.

Journal: Expert opinion on biological therapy

Published: April 26, 2024

Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients.

Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients.

Journal: International journal of molecular sciences

Published: March 03, 2024

Eosinophilic Dermatoses: Cause of Non-Infectious Erythema after Volume Replacement with Diced Acellular Dermal Matrix in Breast Cancer?

Eosinophilic Dermatoses: Cause of Non-Infectious Erythema after Volume Replacement with Diced Acellular Dermal Matrix in Breast Cancer?

Journal: Life (Basel, Switzerland)

Published: January 28, 2024

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study.

Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study.

Journal: Oral oncology

Published: January 18, 2024

Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study.

Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study.

Journal: Anticancer research

Published: November 27, 2023

Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer.

Hounsfield Units Predict Survival of Patients With Estrogen Receptor-Positive and Human Epithelial Growth Factor Receptor 2-Negative Breast Cancer.

Journal: Clinical breast cancer

Published: April 04, 2023

Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer.

Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer.

Journal: International journal of molecular sciences

Published: January 18, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026